313 related articles for article (PubMed ID: 37643975)
21. RNA-based therapeutics: current progress and future prospects.
Burnett JC; Rossi JJ
Chem Biol; 2012 Jan; 19(1):60-71. PubMed ID: 22284355
[TBL] [Abstract][Full Text] [Related]
22. Nucleic Acid Therapeutics in Huntington's Disease.
Singh K; Roy I
Recent Pat Biotechnol; 2019; 13(3):187-206. PubMed ID: 30747088
[TBL] [Abstract][Full Text] [Related]
23. Liver as a target for oligonucleotide therapeutics.
Sehgal A; Vaishnaw A; Fitzgerald K
J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
[TBL] [Abstract][Full Text] [Related]
24. Recent Advances in Oligonucleotide Therapeutics in Oncology.
Xiong H; Veedu RN; Diermeier SD
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33804856
[TBL] [Abstract][Full Text] [Related]
25. Types of RNA therapeutics.
Goleij P; Babamohamadi M; Rezaee A; Sanaye PM; Tabari MAK; Sadreddini S; Arefnezhad R; Motedayyen H
Prog Mol Biol Transl Sci; 2024; 203():41-63. PubMed ID: 38360005
[TBL] [Abstract][Full Text] [Related]
26. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
Mahato RI; Cheng K; Guntaka RV
Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
[TBL] [Abstract][Full Text] [Related]
27. Introduction and History of the Chemistry of Nucleic Acids Therapeutics.
Gait MJ; Agrawal S
Methods Mol Biol; 2022; 2434():3-31. PubMed ID: 35213007
[TBL] [Abstract][Full Text] [Related]
28. [Therapeutic oligonucleotides: a review].
Wang X; Xian J; Chen G; Peng H
Sheng Wu Gong Cheng Xue Bao; 2018 May; 34(5):664-675. PubMed ID: 29893074
[TBL] [Abstract][Full Text] [Related]
29. Antisense oligonucleotides, aptamers and SiRNA: promises for the treatment of ocular diseases.
Fattal E; Bochot A
Arch Soc Esp Oftalmol; 2006 Jan; 81(1):3-4, 5-6. PubMed ID: 16450253
[No Abstract] [Full Text] [Related]
30. [Oligonucleotide therapeutics].
Matsuda Y; Nakamura Y
Nihon Rinsho; 2012 Nov; 70 Suppl 8():393-7. PubMed ID: 23513872
[No Abstract] [Full Text] [Related]
31. A status update of modified oligonucleotides for chemotherapeutics applications.
Sanghvi YS
Curr Protoc Nucleic Acid Chem; 2011 Sep; Chapter 4():Unit 4.1.1-22. PubMed ID: 21901670
[TBL] [Abstract][Full Text] [Related]
32. RNA solutions to treat inborn errors of metabolism.
Martinez-Pizarro A; Desviat LR
Mol Genet Metab; 2022 Aug; 136(4):289-295. PubMed ID: 35849888
[TBL] [Abstract][Full Text] [Related]
33. Nucleic acids-based therapeutics in the battle against pathogenic viruses.
Haasnoot J; Berkhout B
Handb Exp Pharmacol; 2009; 189(189):243-63. PubMed ID: 19048203
[TBL] [Abstract][Full Text] [Related]
34. Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viruses.
Spurgers KB; Sharkey CM; Warfield KL; Bavari S
Antiviral Res; 2008 Apr; 78(1):26-36. PubMed ID: 18258313
[TBL] [Abstract][Full Text] [Related]
35. RNA therapeutics for disorders of excretory system.
Vu TD; Nguyen MA; Jurgoński A; Chu DT
Prog Mol Biol Transl Sci; 2024; 203():245-256. PubMed ID: 38360001
[TBL] [Abstract][Full Text] [Related]
36. Challenges and Opportunities for Nucleic Acid Therapeutics.
Corey DR; Damha MJ; Manoharan M
Nucleic Acid Ther; 2022 Feb; 32(1):8-13. PubMed ID: 34931905
[TBL] [Abstract][Full Text] [Related]
37. Delivery of oligonucleotide-based therapeutics: challenges and opportunities.
Hammond SM; Aartsma-Rus A; Alves S; Borgos SE; Buijsen RAM; Collin RWJ; Covello G; Denti MA; Desviat LR; Echevarría L; Foged C; Gaina G; Garanto A; Goyenvalle AT; Guzowska M; Holodnuka I; Jones DR; Krause S; Lehto T; Montolio M; Van Roon-Mom W; Arechavala-Gomeza V
EMBO Mol Med; 2021 Apr; 13(4):e13243. PubMed ID: 33821570
[TBL] [Abstract][Full Text] [Related]
38. An Insight on RNA Based Therapeutics and Vaccines: Challenges and Opportunities.
Batra K; Maan S; Sehrawat A
Curr Top Med Chem; 2021; 21(32):2851-2855. PubMed ID: 34792013
[TBL] [Abstract][Full Text] [Related]
39. The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses.
Ciccone G; Ibba ML; Coppola G; Catuogno S; Esposito CL
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047090
[TBL] [Abstract][Full Text] [Related]
40. The notorious R.N.A. in the spotlight - drug or target for the treatment of disease.
Reautschnig P; Vogel P; Stafforst T
RNA Biol; 2017 May; 14(5):651-668. PubMed ID: 27415589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
